Sign In

Login

Password

Forgot Password ? Sign Up

STAT5 (French Wikipedia)

Analysis of information sources in references of the Wikipedia article "STAT5" in French language version.

refsWebsite
Global rank French rank
11nih.gov
4th place
12th place
11doi.org
2nd place
3rd place
1endocrinology-journals.org
low place
low place
1jimmunol.org
low place
4,913th place

doi.org (Global: 2nd place; French: 3rd place)

dx.doi.org

  • « Stat5a and Stat5b: fraternal twins of signal transduction and transcriptional activation », Cytokine Growth Factor Rev., vol. 10, no 2,‎ , p. 131–57 (PMID 10743504, DOI 10.1016/S1359-6101(99)00011-8)
  • « STAT5 as a molecular regulator of proliferation, differentiation and apoptosis in hematopoietic cells », EMBO J., vol. 18, no 17,‎ , p. 4754–65 (PMID 10469654, PMCID 1171548, DOI 10.1093/emboj/18.17.4754)
  • « Signal transducer and activator of transcription 5A/B in prostate and breast cancers », Endocr. Relat. Cancer, vol. 15, no 2,‎ , p. 367–90 (PMID 18508994, DOI 10.1677/ERC-08-0013, lire en ligne)
  • « Inhibitors of Stat5 protein signalling », MedChemComm, vol. 3, no 1,‎ , p. 22 (DOI 10.1039/C1MD00175B)
  • « Epigenetic repression of the Igk locus by STAT5-mediated recruitment of the histone methyltransferase Ezh2 », Nat. Immunol., vol. 12, no 12,‎ , p. 1212–20 (PMID 22037603, PMCID 3233979, DOI 10.1038/ni.2136)
  • « Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells », Nat. Med., vol. 2, no 5,‎ , p. 561–6 (PMID 8616716, DOI 10.1038/nm0596-561)
  • « A FLT3-targeted tyrosine kinase inhibitor is cytotoxic to leukemia cells in vitro and in vivo », Blood, vol. 99, no 11,‎ , p. 3885–91 (PMID 12010785, DOI 10.1182/blood.V99.11.3885)
  • « CYT387, a selective JAK1/JAK2 inhibitor: in vitro assessment of kinase selectivity and preclinical studies using cell lines and primary cells from polycythemia vera patients », Leukemia, vol. 23, no 8,‎ , p. 1441–5 (PMID 19295546, DOI 10.1038/leu.2009.50)
  • « Specific inhibition of Stat5a/b promotes apoptosis of IL-2-responsive primary and tumor-derived lymphoid cells », J. Immunol., vol. 171, no 8,‎ , p. 3919–27 (PMID 14530308, DOI 10.4049/jimmunol.171.8.3919, lire en ligne)
  • « Stat3 as a molecular target in RNA interference-based treatment of oral squamous cell carcinoma », Oncol. Rep., vol. 20, no 4,‎ , p. 873–8 (PMID 18813829, DOI 10.3892/or_00000085)
  • « Small molecule STAT5-SH2 domain inhibitors exhibit potent antileukemia activity », J. Med. Chem., vol. 55, no 3,‎ , p. 1047–55 (PMID 22148584, DOI 10.1021/jm200720n)

endocrinology-journals.org (Global: low place; French: low place)

erc.endocrinology-journals.org

jimmunol.org (Global: low place; French: 4,913th place)

nih.gov (Global: 4th place; French: 12th place)

ncbi.nlm.nih.gov

  • « Stat5a and Stat5b: fraternal twins of signal transduction and transcriptional activation », Cytokine Growth Factor Rev., vol. 10, no 2,‎ , p. 131–57 (PMID 10743504, DOI 10.1016/S1359-6101(99)00011-8)
  • « STAT5 as a molecular regulator of proliferation, differentiation and apoptosis in hematopoietic cells », EMBO J., vol. 18, no 17,‎ , p. 4754–65 (PMID 10469654, PMCID 1171548, DOI 10.1093/emboj/18.17.4754)
  • « Signal transducer and activator of transcription 5A/B in prostate and breast cancers », Endocr. Relat. Cancer, vol. 15, no 2,‎ , p. 367–90 (PMID 18508994, DOI 10.1677/ERC-08-0013, lire en ligne)
  • « Epigenetic repression of the Igk locus by STAT5-mediated recruitment of the histone methyltransferase Ezh2 », Nat. Immunol., vol. 12, no 12,‎ , p. 1212–20 (PMID 22037603, PMCID 3233979, DOI 10.1038/ni.2136)
  • « Constitutive activation of STAT5 by the BCR-ABL oncogene in chronic myelogenous leukemia », Oncogene, vol. 13, no 2,‎ , p. 247–54 (PMID 8710363)
  • « Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells », Nat. Med., vol. 2, no 5,‎ , p. 561–6 (PMID 8616716, DOI 10.1038/nm0596-561)
  • « A FLT3-targeted tyrosine kinase inhibitor is cytotoxic to leukemia cells in vitro and in vivo », Blood, vol. 99, no 11,‎ , p. 3885–91 (PMID 12010785, DOI 10.1182/blood.V99.11.3885)
  • « CYT387, a selective JAK1/JAK2 inhibitor: in vitro assessment of kinase selectivity and preclinical studies using cell lines and primary cells from polycythemia vera patients », Leukemia, vol. 23, no 8,‎ , p. 1441–5 (PMID 19295546, DOI 10.1038/leu.2009.50)
  • « Specific inhibition of Stat5a/b promotes apoptosis of IL-2-responsive primary and tumor-derived lymphoid cells », J. Immunol., vol. 171, no 8,‎ , p. 3919–27 (PMID 14530308, DOI 10.4049/jimmunol.171.8.3919, lire en ligne)
  • « Stat3 as a molecular target in RNA interference-based treatment of oral squamous cell carcinoma », Oncol. Rep., vol. 20, no 4,‎ , p. 873–8 (PMID 18813829, DOI 10.3892/or_00000085)
  • « Small molecule STAT5-SH2 domain inhibitors exhibit potent antileukemia activity », J. Med. Chem., vol. 55, no 3,‎ , p. 1047–55 (PMID 22148584, DOI 10.1021/jm200720n)